• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩的神经病理学及其治疗意义。

The neuropathology of multiple system atrophy and its therapeutic implications.

作者信息

Valera Elvira, Masliah Eliezer

机构信息

Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093, USA.

Division of Neurosciences, National Institute on Aging/NIH, 7201 Wisconsin Ave, Bethesda, MD 20814, USA.

出版信息

Auton Neurosci. 2018 May;211:1-6. doi: 10.1016/j.autneu.2017.11.002. Epub 2017 Nov 10.

DOI:10.1016/j.autneu.2017.11.002
PMID:29169744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5954415/
Abstract

Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by the abnormal accumulation of toxic forms of the synaptic protein alpha-synuclein (α-syn) within oligodendrocytes and neurons. The presence of α-syn within oligodendrocytes in the form of glial cytoplasmic inclusions is the diagnostic hallmark of MSA. However, it has been postulated that α-syn is produced in neurons and propagates to oligodendrocytes, where unknown mechanisms lead to its accumulation. The presence of α-syn within neurons in MSA has not been so extensively studied, but it may shed light into neuropathological mechanisms leading to oligodendroglial accumulation. Here we summarize the principal neuropathological events of MSA, and discuss how a deeper knowledge of these mechanisms may help develop effective therapies targeting α-syn accumulation and spreading.

摘要

多系统萎缩(MSA)是一种致命的神经退行性疾病,其特征是突触蛋白α-突触核蛋白(α-syn)的毒性形式在少突胶质细胞和神经元内异常积聚。少突胶质细胞内以胶质细胞质内含物形式存在的α-syn是MSA的诊断标志。然而,据推测α-syn在神经元中产生并传播到少突胶质细胞,在少突胶质细胞中未知机制导致其积聚。MSA中神经元内α-syn的存在尚未得到如此广泛的研究,但它可能有助于揭示导致少突胶质细胞积聚的神经病理机制。在这里,我们总结了MSA的主要神经病理事件,并讨论了对这些机制的更深入了解如何有助于开发针对α-syn积聚和扩散的有效疗法。

相似文献

1
The neuropathology of multiple system atrophy and its therapeutic implications.多系统萎缩的神经病理学及其治疗意义。
Auton Neurosci. 2018 May;211:1-6. doi: 10.1016/j.autneu.2017.11.002. Epub 2017 Nov 10.
2
Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.在模拟α-突触核蛋白病的小鼠中,神经元α-突触核蛋白病增多与少突胶质细胞中α-突触核蛋白的积累有关。
PLoS One. 2012;7(10):e46817. doi: 10.1371/journal.pone.0046817. Epub 2012 Oct 15.
3
Neuropathology of multiple system atrophy: new thoughts about pathogenesis.多系统萎缩的神经病理学:关于发病机制的新思考
Mov Disord. 2014 Dec;29(14):1720-41. doi: 10.1002/mds.26052. Epub 2014 Oct 9.
4
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.新型少突胶质细胞α-突触核蛋白病毒载体模型的多系统萎缩:啮齿动物和非人灵长类动物的研究。
Acta Neuropathol Commun. 2017 Jun 16;5(1):47. doi: 10.1186/s40478-017-0451-7.
5
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.少突胶质细胞中α-突触核蛋白的过表达不能重现多系统萎缩中观察到的纤维状聚集。
Cells. 2020 Oct 29;9(11):2371. doi: 10.3390/cells9112371.
6
The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.分子镊子 CLR01 降低了实验性多系统萎缩中聚集的、病理性的和具有成核能力的α-突触核蛋白。
Biochim Biophys Acta Mol Basis Dis. 2019 Nov 1;1865(11):165513. doi: 10.1016/j.bbadis.2019.07.007. Epub 2019 Jul 16.
7
Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.少突胶质细胞α-突触核蛋白病驱动的多系统萎缩神经炎症。
Brain Pathol. 2019 May;29(3):380-396. doi: 10.1111/bpa.12678. Epub 2019 Jan 31.
8
Review: Multiple system atrophy: emerging targets for interventional therapies.综述:多系统萎缩:介入治疗的新靶点
Neuropathol Appl Neurobiol. 2016 Feb;42(1):20-32. doi: 10.1111/nan.12304.
9
SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.SNCA 和 TPPP 转录本在多系统萎缩的少突胶质细胞质包涵体中增加。
Neurobiol Dis. 2024 Aug;198:106551. doi: 10.1016/j.nbd.2024.106551. Epub 2024 Jun 3.
10
Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad.多系统萎缩:α-突触核蛋白在神经元-少突胶质细胞交叉路口的聚集。
Mol Neurodegener. 2022 Nov 26;17(1):77. doi: 10.1186/s13024-022-00579-z.

引用本文的文献

1
Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies.健康衰老和突触核蛋白病中黑质纹状体铁沉积的梯度变化
CNS Neurosci Ther. 2025 Mar;31(3):e70359. doi: 10.1111/cns.70359.
2
Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson's disease.邻近蛋白质组学揭示了多系统萎缩与帕金森病之间独特且共有的病理特征。
Acta Neuropathol Commun. 2025 Mar 23;13(1):65. doi: 10.1186/s40478-025-01958-5.
3
Toward a biological definition of neuronal and glial synucleinopathies.迈向神经元和胶质细胞α-突触核蛋白病的生物学定义。
Nat Med. 2025 Feb;31(2):396-408. doi: 10.1038/s41591-024-03469-7. Epub 2025 Jan 30.
4
Comparing alpha-synuclein-interactomes between multiple systems atrophy and Parkinson's disease reveals unique and shared pathological features.比较多系统萎缩和帕金森病之间的α-突触核蛋白相互作用组揭示了独特和共有的病理特征。
bioRxiv. 2024 Sep 21:2024.09.20.613717. doi: 10.1101/2024.09.20.613717.
5
Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy.多系统萎缩中胶质细胞和神经元α-突触核蛋白包涵体的独特超微结构表型。
Brain. 2024 Nov 4;147(11):3727-3741. doi: 10.1093/brain/awae137.
6
Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials.多系统萎缩:生物标志物与临床试验的最新进展及新方向
J Neurol. 2024 May;271(5):2324-2344. doi: 10.1007/s00415-024-12269-5. Epub 2024 Mar 14.
7
Distinct forebrain regions define a dichotomous astrocytic profile in multiple system atrophy.不同的前脑区域定义了多系统萎缩中两种不同的星形胶质细胞表型。
Acta Neuropathol Commun. 2024 Jan 2;12(1):1. doi: 10.1186/s40478-023-01699-3.
8
Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models.突触核蛋白病大脑及实验模型中α-突触核蛋白细丝的超微结构
J Mov Disord. 2024 Jan;17(1):15-29. doi: 10.14802/jmd.23213. Epub 2023 Nov 22.
9
Multiple system atrophy - a clinicopathological update.多系统萎缩——临床病理新进展
Free Neuropathol. 2020 Jul 3;1:17. doi: 10.17879/freeneuropathology-2020-2813. eCollection 2020 Jan.
10
Gene Set Enrichment Analysis and Genetic Experiment Reveal Changes in Cell Signaling Pathways Induced by α-Synuclein Overexpression.基因集富集分析和遗传实验揭示了由α-突触核蛋白过表达诱导的细胞信号通路变化。
Biomedicines. 2023 Jan 18;11(2):263. doi: 10.3390/biomedicines11020263.

本文引用的文献

1
Therapeutic approaches to target alpha-synuclein pathology.针对α-突触核蛋白病变的治疗方法。
Exp Neurol. 2017 Dec;298(Pt B):225-235. doi: 10.1016/j.expneurol.2017.10.003. Epub 2017 Oct 4.
2
Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy.在多系统萎缩的转基因小鼠模型中,进行α-突触核蛋白免疫疗法与抗炎治疗相结合的研究。
Acta Neuropathol Commun. 2017 Jan 5;5(1):2. doi: 10.1186/s40478-016-0409-1.
3
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.抗α-突触核蛋白单克隆抗体PRX002在健康志愿者中的首次人体评估。
Mov Disord. 2017 Feb;32(2):211-218. doi: 10.1002/mds.26878. Epub 2016 Nov 25.
4
A genome-wide association study in multiple system atrophy.多系统萎缩的全基因组关联研究。
Neurology. 2016 Oct 11;87(15):1591-1598. doi: 10.1212/WNL.0000000000003221. Epub 2016 Sep 14.
5
Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.多系统萎缩转基因模型中表观遗传调控的神经保护作用
Neurotherapeutics. 2016 Oct;13(4):871-879. doi: 10.1007/s13311-016-0447-1.
6
α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.α-突触核蛋白诱导的髓鞘形成缺陷确定了多系统萎缩的一个新的干预靶点。
Acta Neuropathol. 2016 Jul;132(1):59-75. doi: 10.1007/s00401-016-1572-y. Epub 2016 Apr 8.
7
Review: Multiple system atrophy: emerging targets for interventional therapies.综述:多系统萎缩:介入治疗的新靶点
Neuropathol Appl Neurobiol. 2016 Feb;42(1):20-32. doi: 10.1111/nan.12304.
8
Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation.多系统萎缩中的神经炎症:对α-突触核蛋白聚集的反应及原因
Front Cell Neurosci. 2015 Nov 12;9:437. doi: 10.3389/fncel.2015.00437. eCollection 2015.
9
Combination therapies: The next logical Step for the treatment of synucleinopathies?联合疗法:治疗突触核蛋白病的下一个合理步骤?
Mov Disord. 2016 Feb;31(2):225-34. doi: 10.1002/mds.26428. Epub 2015 Sep 21.
10
Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration.长期多系统萎缩患者软脑膜下和脑室周围星形胶质细胞中磷酸化α-突触核蛋白的积累。
Neuropathology. 2016 Apr;36(2):157-67. doi: 10.1111/neup.12243. Epub 2015 Aug 31.